Jessica T Leonard

11PUBLICATIONS

94CO-AUTHORS

PhysiotherapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 25, 2026

Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALL.

|May 19, 2026

Consensus Recommendations for CAR T-Cell Administration in Adult Acute Lymphoblastic Leukemia: a Modified Delphi Study.

|Feb 05, 2026

Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL.

Hrishikesh Krishna Srinagesh, Vishal K Gupta, Amy Zhang

|Aug 23, 2025

The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.

Timothy E O'Connor, Chenyu Lin, Gregory W Roloff

|May 21, 2025

Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.

Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena

|May 07, 2025

Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.

Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand

Pageof 2

Frequent Collaborators

Lori S Muffly

Aaron C Logan

LaQuisa C Hill

Joshua Sasine

Navneet S Majhail

Noelle V Frey

Chenyu Lin

Matthew P Connor

Gregory W Roloff

Kaitlyn C Dykes

Frequent Collaborators

Lori S Muffly

Aaron C Logan

LaQuisa C Hill

Joshua Sasine